Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

IM Cannabis Corp. (C:IMCC)

Business Focus: N/A

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 550 Burrard Street, Suite 2300
VANCOUVER BC V6C 2B5
Tel: N/A
Website: https://imcannabis.com
IR: See website
Key People
Marc Lustig
Executive Chairman of the Board
Oren Shuster
Chief Executive Officer, Director
Steven Michael Mintz
Chief Financial Officer
Business Overview
IM Cannabis Corp., formerly Navasota Resources Inc., is a Canada-based medical cannabis company. The company is focused on offering a full spectrum of government-licensed cannabis products, from generic to good manufacturing practice (GMP) certified and pharmaceutical-grade, for both wholesale and retail clients. The Company operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. The Company has three wholly-owned subsidiaries: IMC, incorporated, IMC Portugal and IM Cannabis Canada Inc. The Company also has four partially-owned subsidiaries Adjupharm GmbH, IMC Ventures Ltd., Societe Amig Navasota Mining International S.A.R.L., and Africa Bauxite Corporation.
Financial Overview
For the six months ended 30 June 2021, IM CannabisCorp revenues increased from C$5.1M to C$19.9M. Net lossdecreased 99% to C$125K. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Lower net loss reflectsFinance expense decrease of 89% to C$846K (expense),Research and development expenses decrease of 96% to C$6K(expense).
Reporting Currency: Canadian Dollars
Enterprise value: $296.06M as of Jun 30, 2021
Annual revenue (TTM): $30.67M as of Jun 30, 2021
EBITDA (TTM): -$26.72M as of Jun 30, 2021
Net annual income (TTM): -$18.83M as of Jun 30, 2021
Free cash flow (TTM): -$28.85M as of Jun 30, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 67,544,445 as of Sep 8, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization